Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Borqs Technologies Inc is a software-application business based in the US. Borqs Technologies shares (BRQS) are listed on the NASDAQ and all prices are listed in US Dollars. Borqs Technologies employs 286 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$0.56|
|52-week range||$0.49 - $3.35|
|50-day moving average||$0.67|
|200-day moving average||$0.88|
|Wall St. target price||$12.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.80|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-0.89%|
|1 month (2021-09-24)||-16.16%|
|3 months (2021-07-23)||-31.73%|
|6 months (2021-04-23)||-50.00%|
|1 year (2020-10-23)||-52.16%|
|2 years (2019-10-20)||N/A|
|3 years (2018-10-23)||4.25|
|5 years (2016-10-20)||N/A|
Valuing Borqs Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Borqs Technologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Borqs Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $8.3 million.
The EBITDA is a measure of a Borqs Technologies's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$28.2 million|
|Gross profit TTM||$1.6 million|
|Return on assets TTM||-63.22%|
|Return on equity TTM||0%|
|Market capitalisation||$82 million|
TTM: trailing 12 months
There are currently 2.5 million Borqs Technologies shares held short by investors – that's known as Borqs Technologies's "short interest". This figure is 12.2% down from 2.9 million last month.
There are a few different ways that this level of interest in shorting Borqs Technologies shares can be evaluated.
Borqs Technologies's "short interest ratio" (SIR) is the quantity of Borqs Technologies shares currently shorted divided by the average quantity of Borqs Technologies shares traded daily (recently around 3.6 million). Borqs Technologies's SIR currently stands at 0.69. In other words for every 100,000 Borqs Technologies shares traded daily on the market, roughly 690 shares are currently held short.
However Borqs Technologies's short interest can also be evaluated against the total number of Borqs Technologies shares, or, against the total number of tradable Borqs Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Borqs Technologies's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Borqs Technologies shares in existence, roughly 20 shares are currently held short) or 0.0433% of the tradable shares (for every 100,000 tradable Borqs Technologies shares, roughly 43 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Borqs Technologies.
Find out more about how you can short Borqs Technologies stock.
We're not expecting Borqs Technologies to pay a dividend over the next 12 months.
Over the last 12 months, Borqs Technologies's shares have ranged in value from as little as $0.492 up to $3.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Borqs Technologies's is 2.0265. This would suggest that Borqs Technologies's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Borqs Technologies, Inc. , through its subsidiaries, focuses on software, development services, and products that provides Android-based smart connected devices and cloud service solutions in China, India, the United States, and internationally. The company offers commercial grade Android platform software and service solutions to address vertical market segment needs through the targeted BorqsWare software platform solutions. Its BorqsWare software platform consists of BorqsWare Client software that has been used in Android phones, tablets, watches, and various Internet-of-things devices; and BorqsWare Server software platform that includes back-end server software that allows customers to develop their own mobile end-to-end services for their devices. The company primarily serves mobile chipset manufacturers, mobile device original equipment manufacturers, and mobile operators, as well as product solutions of mobile connected devices for enterprise and consumer applications. Borqs Technologies, Inc. was founded in 2007 and is headquartered in Beijing, China.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.